COX2 Overexpression

CI-VAR-00003227Explore in graph →CIViC 3734

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
HER2 Negative Breast Cancer1unmapped disease
COX2 Overexpression	Celecoxib	Predictive	B	Supports Sensitivity Response	1	submitted	EID10155 Analysis of 156 breast cancer samples from the REMAGUS-02 randomized phase II trial indicated potential clinical significance of COX2 expression with celecoxib treatment. Patient population characteri… (full text at CIViC) PMID 29491076 · DE Cremoux et al., 2018 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.